1. ADAMTS5 promotes neovascularization via autophagic degradation of PEDF in proliferative diabetic retinopathy
   Zhao Geng et al, 2023, Experimental Eye Research CrossRef
2. In vitro laboratory models of proliferative vitreoretinopathy
   Ashley Y. Gao et al, 2023, Survey of Ophthalmology CrossRef
3. Effect of Oral Prednisone on the Prevention and Management of Proliferative Vitreoretinopathy After Open-Globe Injury
   Tianyuan Yao et al, 2024, Journal of VitreoRetinal Diseases CrossRef
4. Investigation of novel combination therapy for age-related macular degeneration on ARPE-19 cells
   Madhuri Dandamudi et al, 2024, Frontiers in Drug Delivery CrossRef
5. Network pharmacology and molecular docking to explore Siraitia grosvenorii’s potential mechanism in preventing and treating proliferative diabetic retinopathy
   Yehong Zhou et al, 2022, Frontiers in Drug Discovery CrossRef
6. Cell Division Control Protein 42 Facilitates Diabetic Retinopathy Progression by Activating the MEK/ERK Pathway
   Hui Cao et al, 2023, The Tohoku Journal of Experimental Medicine CrossRef
7. Bone morphogenetic protein 6 (BMP6) antagonises experimental proliferative vitreoretinopathy established by TGF-β2 stimulation in retinal pigment epithelial cells through modulation of the p38 and JNK MAPK pathways
   Xuan Liu et al, 2024, Cell and Tissue Research CrossRef
8. Role of Autotaxin in High Glucose-Induced Human ARPE-19 Cells
   Yang Liu et al, 2022, International Journal of Molecular Sciences CrossRef